611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA News: Emphysema May Raise Risk of Ruptured AneurysmsNew Facial Bone Might Someday Be Grown From the Patient's RibWhat Works Best for Women Struggling With a Leaky Bladder?Your Apple Watch Might Help Spot a Dangerous Irregular HeartbeatDocs Back Away From Low-Dose Aspirin for Heart Attack PreventionAHA News: Overweight Kids at Higher Risk for Blood Clots as AdultsEbola Survivors Continue to Suffer Years After RecoveryFewer Boys Are Suffering Head Injuries, But Rate Rises for GirlsAHA News: Black Woman in Their 50s Face Especially High Stroke RiskNew Drug Could Help Those With Tough-to-Treat CholesterolWhen Can Kids Return to Play After a Concussion?Need to Be Vaccinated? Try Your Local PharmacyOne-Third of U.S. Kids Have Back Pain, Study SaysBlacks, Hispanics Bear Burden of Air Pollution: StudyChickens Help Scientists Pinpoint Origin of Rare, Deadly VirusDry Eye and Migraines Might Be Linked: StudySkin Fungi May Be Tied to Bowel DiseaseYo-Yo Dieting Can Take a Toll on Your HeartAHA News: Opioid Meds Pose Danger to Kidney Disease PatientsHealth Tip: UTI Warning SignsStaph Infections Drop, but Levels Still Worry U.S. Health OfficialsTreatment May Allow Allergic Kids to Eat Eggs Safely: StudyAcne Drug Accutane May Not Depress Mood After AllHealth Tip: Preventing Carpal TunnelMajor Flooding Can Bring Skin Infection DangersSmall Trial Provides New Hope Against Parkinson's DiseaseIs Your Hand Pain Arthritis, Carpal Tunnel or Something Else?California Parents Are Getting Around Vaccine Law, Fueling Measles OutbreaksSeniors With UTIs Need Antibiotics ASAP, Study SaysWhy Do Some Kids With Eczema Develop Food Allergies?High-Fiber Diet May Help Gut 'Microbiome' Battle MelanomaTick Bites More Likely to Cause Red Meat Allergy Than ThoughtWalking, Not Riding, Boosts Health in Golfers With Knee WoesIs At-Home Stool Test a Viable Alternative to Colonoscopy?After Peanut Allergy Rx, Eating Small Bits of Peanut Might Help: StudyA Hard Look at Smoking's Effect on VisionPeanut Allergy Patch Shows Middling Results in TrialToxins in Home Furnishings Can Be Passed on to KidsKratom-Related Poisonings Are Soaring, Study FindsFDA Aims to Strengthen Sunscreen RulesBrain Condition CTE Seen in H.S. Football Players: StudyPregnant Women Should Delay Gallbladder Surgery, Study FindsGut Microbes May Help Drive Lupus, Study FindsMost Hip, Knee Replacements Last Decades, Study FindsAHA News: Living Near Convenience Stores Could Raise Risk of Artery-Clogging ConditionPossible Parkinson's 'Pandemic' Looms: Report'Apple-Shaped' Body? 'Pear-Shaped'? Your Genes May TellProtect Your Aging Eyes From Macular DegenerationKidney Failure Patients Face Higher Risk of Cancer DeathHow Inactivity and Junk Food Can Harm Your Brain
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Peanut Allergy Patch Shows Middling Results in Trial

HealthDay News
by By E.J. Mundell
HealthDay Reporter
Updated: Feb 22nd 2019

new article illustration

FRIDAY, Feb. 22, 2019 (HealthDay News) -- Delivering "exposure therapy" via a patch to help curb peanut allergy in kids is somewhat effective, but not as good as delivering the tiny amounts of peanut by mouth, new research shows.

The international trial involved 356 children, aged 4 to 11, from five countries. All had been diagnosed with peanut allergy and were asked to wear either a skin patch with a very tiny amount of peanut allergen (250 micrograms) or a placebo patch without any allergen.

They were later tested with a "peanut challenge," where a child is gradually fed an increasing (but still tiny) dose of peanut, from 1 milligram up to 300 milligrams.

The result: About a third of the kids who'd been wearing the patch (35.3 percent) seemed to have benefited, with a lessening of response to the peanut challenge. That was true for just 13.6 percent of children who'd worn the placebo patch, according to a team led by Dr. David Fleischer of Children's Hospital Colorado in Aurora.

Still, that means the peanut allergy patch did not help two-thirds of the children who used it.

And for ethical reasons, kids with severe peanut allergies who'd experienced a life-threatening reaction -- and could benefit most from treatment -- weren't included in the new trial.

One allergist who wasn't involved in the study believes more tweaking to the therapy may be needed.

"This study confirms that the peanut patch is effective in treatment of peanut allergy, but the response rate is not as robust as previously expected," said Dr. Punita Ponda. She's assistant chief of the department of allergy and immunology at Northwell Health in Great Neck, N.Y.

Ponda said it's generally known that delivery of "exposure therapy" via mouth outperforms methods such as a patch, but risks of sudden anaphylactic reactions may rise with oral administration. So, she remains hopeful that patch therapy may still become an option.

"It is expected that this treatment will have a place in the future treatment of food allergy," Ponda said, "but the details of dosing and expected response rates will have to be clarified."

The study was funded by biopharmaceutical company DBV Technologies and was published Feb. 22 in JAMA Network Open.

In an editorial accompanying the study, journal deputy editor Dr. Jody Zylke said that "the theoretical advantages of this [patch] approach include ease of use and a lower risk of allergic reactions."

In fact, she noted that tolerance of the patch was very high -- 98.5 percent of patients used the treatment as directed.

But Zylke added that the results of the new trial are "not easy to interpret." Regardless of statistics-based arguments about the significance of the new findings, doctors "will have to determine with patients whether a response of 35.3 percent with the peanut patch is worthwhile," she said.

More information

The American College of Allergy, Asthma & Immunology offers more on peanut allergy.